DOCK2 Deficiency Diagnosed 18 Years After Hematopoietic Stem Cell Transplantation

J Clin Immunol. 2021 Aug;41(6):1400-1402. doi: 10.1007/s10875-021-01040-4. Epub 2021 Apr 30.

Katherine D'Astous-Gauthier¹, Aléhandra Desjardins^#^{2

3}, Louis Marois^{4

5}, Emilia Liana Falcone^{3

4

5}, Hugo Chapdelaine^{6

7}

¹ Department of Pediatric, Clinical Immunology and Allergy, University of Sherbrooke, Sherbrooke, QC, Canada.
² Department of Microbiology, Infectiology and Immunology, University of Montreal, Quebec, Canada.
³ Department of Immunity and Viral Infections, Montreal Clinical Research Institute (IRCM), Montreal, QC, Canada.
⁴ Department of Medicine, University of Montreal, Montreal, QC, Canada.
⁵ Adult Clinical Immunology Clinic, Montreal Clinical Research Institute (IRCM), 110 avenue des Pins Ouest, Montreal, QC, H2W 1R7, Canada.
⁶ Department of Medicine, University of Montreal, Montreal, QC, Canada. [email protected].
⁷ Adult Clinical Immunology Clinic, Montreal Clinical Research Institute (IRCM), 110 avenue des Pins Ouest, Montreal, QC, H2W 1R7, Canada. [email protected].

^# Contributed equally.

No abstract available

Keywords: Colitis; DOCK2; Hematopoietic stem cell transplantation; combined immunodeficiency; primary immunodeficiency.

Publication types